Instil Bio Inc. Market Cap ($47.41 Million)
Market Cap & Net Worth: Instil Bio Inc. (TIL)
Instil Bio Inc. market cap. Instil Bio Inc. (NASDAQ:TIL) has a market capitalization of $47.41 Million ($47.41 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #21921 globally and #4893 in its home market, demonstrating a 19.69% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Instil Bio Inc.'s stock price $6.99 by its total outstanding shares 6781976 (6.78 Million). Also see Instil Bio Inc. (TIL) cash flow conversion for how efficiently the company converts equity into cash flow.
Instil Bio Inc. Market Cap History (2021–2026)
Instil Bio Inc. market cap history from 2021 to 2026. Data shows change from $2.32 Billion to $47.41 Million (-53.61% CAGR). Check Instil Bio Inc. share price for real-time trading data and today's change.
Index Memberships
Instil Bio Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.00% | #624 of 976 |
|
NASDAQ Composite
IXIC
|
$40.12 Trillion | 0.00% | #2074 of 3165 |
Weight: Instil Bio Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Instil Bio Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Instil Bio Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Instil Bio Inc. growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TIL by Market Capitalization
Companies near Instil Bio Inc. in the global market cap rankings as of November 5, 2026. Also see Instil Bio Inc. total assets for a full breakdown of the balance sheet.
Key companies related to Instil Bio Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #181 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #373 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #415 globally with a market cap of $67.74 Billion USD ( AU$95.74 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #503 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #181 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $549.04 |
| #373 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $930.67 |
| #415 | CSL Ltd | AU:CSL | $67.74 Billion | AU$197.34 |
| #503 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $258.38 |
Market Capitalization of Instil Bio Inc. (2021–2026)
Market capitalization of Instil Bio Inc. from 2021 to today. Between 2021 and today, Instil Bio Inc.'s market cap moved from $2.32 Billion to $ 47.41 Million, with a yearly change of -53.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $47.41 Million | -36.45% |
| 2025 | $74.60 Million | -42.38% |
| 2024 | $129.47 Million | +150.52% |
| 2023 | $51.68 Million | -39.52% |
| 2022 | $85.45 Million | -96.32% |
| 2021 | $2.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Instil Bio Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $47.41 Million USD |
| MoneyControl | $47.41 Million USD |
| MarketWatch | $47.41 Million USD |
| marketcap.company | $47.41 Million USD |
| Reuters | $47.41 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Instil Bio Inc.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.